ANATOLIA ACADEMY

PRECEPTORSHIP WORKSHOPS

Anatolia IVF deeply believes that the spirit of science is to share scientific knowledge and expertise. Hence, Anatolia IVF has been organizing preceptorship programs (2 or 3 day) to physicians and embryologists from diverse countries to share the recent, cutting-edge practice in IVF.

The organized workshops include;

VI. Preceptorship Program (V. Chinese Preceptorship), April 23-24, 2018, Ankara, Turkey (12 Chinese participants with theoretical and practical education)
V. Preceptorship Program (IV. Chinese Preceptorship), March 16-18, 2016, Ankara, Turkey (15 Chinese participants with theoretical and practical education)
IV. Preceptorship Program, (III. Chinese Preceptorship), September 18-20, 2015, Ankara, Turkey (15 Chinese participants with theoretical and practical education)
III. Preceptorship Program (I. Russian Preceptorship), May 5-7, 2015, Ankara, Turkey (11 Russian participants with theoretical and practical education)
II. Preceptorship Program (II. Chinese Preceptorship), February 11-13, 2015, Ankara, Turkey (15 Chinese participants with theoretical and practical education)
I. Preceptorship Program (I. Chinese Preceptorship), October 8-10, 2014, Ankara, Turkey (15 Chinese participants with theoretical and practical education)
SHAPE in-Clinic Workshop (Shaping Best Clinical Experience and Expertise) Meeting-II; December 1-2, 2011, Ankara (8 participants; Canada, France, Iran, Sudan, Greece, Denmark with theoretical and practical education)
SHAPE in-Clinic Workshop (Shaping Best Clinical Experience and Expertise) Meeting-I; The first SHAPE Meeting in Turkey hosted by Prof. Yarali; December 2-3, 2010, Ankara (15 participants; France, Greece, Egypt, Ukraine, Serbia, Yemen, Iran, Canada, KSA with theoretical and practical education)

A new 3-day preceptorship workshop will be organized in May 2019 at Anatolia.

INTERNATIONAL PROJECTS

Anatolia IVF is a part of several multi-center international projects including;

Institutional grant for research project “In-vitro activation in patients with premature ovarian failure under 36 years old”, Multi-center research project: Professor Aaron Hsueh (Stanford University), Professor Kazuhiro Kawamura (Narita University, Japan) & Professor Hakan Yarali (Hacettepe University), Hacettepe University, Fund for Medical Research Projects (Project No= 15469).
Multi-center research project: “Evaluation of the Previvo Genetics Uterine Lavage System For Recovery of Human Preimplantation Embryos” conducted by Previvo company (US); Scientific Director: Professor John Buster (US)-Currently ongoing.
Multi-center research project: “Validation of ART prediction calculator for estimating the probability of achieving at least one euploid blastocyst for transfer in each IVF/ICSI patient as a function of a given number of oocytes” conducted by Dr. Filippo Ubaldi (Genera IVF Centers, Italy) and Dr. Sandro Esteves (Androfert, Brasil) & Dr. H. Yarali - Currently ongoing. Funded by Merck KGaA.
Multi-center research project: “Prevalence of patients classified according to the POSEIDON criteria and risk Factors for POSEIDON Groups 1 and 2” conducted by Dr. Sandro Esteves (Androfert, Brasil) & Dr. H. Yarali - Currently ongoing.
Multi-center research project: A Phase III Trial to assess the efficacy and safety of Pergoveris (follitropin-alpha and lutropin) and Gonal-F (follitropin alpha), in poor ovarian responders, as defined by ESHRE criteria, undergoing ART treatmen (ESPART Trial). ClinicalTrials.gov identifier: NCT 02047227. Sponsored by Merck KGaA.